Narcolepsy trials in Sweden
4 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Huddinge
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-524711-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Huddinge
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-523911-13-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Huddinge
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-523912-35-00 - Phase 2/3Taking peopleA Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Where
- Uppsala
- Age
- 16 years to 70 years
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT05816382 · EU 2023-508462-15-00